← Eichor
Condition: Fluid Therapy Synced from ClinicalTrials.gov · July 29, 2026

Recruiting studies: Fluid Therapy

Studies currently listed as recruiting on the public registry for this search term. Each page explains the study in plain language, with locations and the study team's contact details. Clinicians: generate a printable list for your patient →

Early Initiated Vasopressor Therapy in the Emergency Department
Phase 3 · 8 location(s) · Odense University Hospital · NCT05931601
Efficacy of Intraoperative Use of 20% Albumin Combined With Ringer Lactate Versus Ringer Lactate During Cytoreductive Su
NA · 7 location(s) · Assistance Publique - Hôpitaux de Paris · NCT06351475
FOLICOLOR TRIAL: Following Therapy Response Through Liquid Biopsy in Metatstatic Colorectal Cancer Patients
Phase 3 · 9 location(s) · University Hospital, Antwerp · NCT07558083
Efficacy of First-Line Immunotherapy in Metastatic Melanoma in Slovenia and Identification of Predictive Biomarkers
NA · 1 location(s) · Institute of Oncology Ljubljana · NCT07407166
ctDNA Monitoring to Predict the Efficacy of TNT for Rectal Cancer
Phase N/A · 1 location(s) · Gene Solutions · NCT06589388
Early Deresuscitation Strategy Driven by Tissue Perfusion in Renal Replacement Therapy in Patients With Acute Renal Fail
NA · 14 location(s) · Hospices Civils de Lyon · NCT05817539
Using a Blood Test and Software Tool to Guide Treatment for Venous Thromboembolism
NA · 8 location(s) · Memorial Sloan Kettering Cancer Center · NCT07399977
Liquid Biospy for Urinary Cancers
Phase N/A · 1 location(s) · IRCCS San Raffaele · NCT06116396
Hydroxyethyl Starch Versus Crystalloid and Postoperative Major Adverse Kidney Complications
Phase 4 · 4 location(s) · Seoul National University Hospital · NCT07410988
Maxillomandibular Advancement Surgery for Treatment of Obstructive Sleep Apnoea Syndrome
NA · 1 location(s) · Jani Talvilahti · NCT07446634
Intermittent or Continuous Panitumumab Plus FOLFIRI for Left Sided RAS/B-RAF Wild-type Metastatic Colorectal Cancer
Phase 3 · 1 location(s) · National Cancer Institute, Naples · NCT06509126
Echocardiography-guided Cirrhosis and Liver Failure-Intensive Care Protocol Sepsis
NA · 1 location(s) · Post Graduate Institute of Medical Education and Research, C · NCT07286643
ARCTIC: Liquid Biomarkers in the Prospective Androgen Receptor Signaling Inhibitors (ARSI) Resistance Clinical Trials
Phase N/A · 3 location(s) · Duke University · NCT06141993
Primary and Acquired Resistance to Targeted Treatment in BRAF V600E-mutated Metastatic Colorectal Cancer
Phase N/A · 13 location(s) · Swiss Cancer Institute · NCT07617610
Treatment of Neovascular AMD: Artificial Intelligence in Real-world Setting
Phase 4 · 1 location(s) · Medical University of Vienna · NCT05093374
3-Month Clinical Trial of Liquid S-PRF in Periodontal Debridement for Periodontitis Stages II-IV
Phase 2 · 1 location(s) · Mahsa University · NCT07293962
Effect of Giving Reduced Fluid in Children After Trauma
NA · 4 location(s) · Columbia University · NCT04201704
TALENT Study: Phase II Trial of Adjuvant L-TIL Plus Tislelizumab in Resectable NSCLC Without pCR After Neoadjuvant Chemo
Phase 2 · 1 location(s) · Tianjin Medical University Cancer Institute and Hospital · NCT07330037
Goal-directed Fluid Therapy During Deep Inferior Epigastric Perforator (DIEP) Free Flap Breast Reconstruction
Phase 4 · 1 location(s) · Algemeen Ziekenhuis Maria Middelares · NCT06080178
Novel Epigenetic Mapping in Cell-Free DNA for the Detection of Lung Cancer
Phase N/A · 1 location(s) · JaxBio Ltd · NCT06963307
Efficacy and Safety of Prunella Oral Liquid in the Treatment of Thyroid Nodules
Phase 4 · 22 location(s) · Xintian Pharmaceutical · NCT06423235
Fluid Guided Heart Failure Treatment at the Cleveland Clinic
NA · 1 location(s) · Bodyport Inc. · NCT07205120
INTUPRO in the Treatment of Benign Prostatic Hyperplasia-Related Symptoms
NA · 1 location(s) · inTumo Therapeutics, Inc. · NCT07381127
Personalized Treatment of Refractory BPPV
NA · 1 location(s) · Hospital Clinico Universitario de Santiago · NCT06725966
Gelaspan vs Crystalloid Therapy in Sepsis
Phase 4 · 9 location(s) · Shanghai Zhongshan Hospital · NCT07172451
Thoracic Fluid Content During Stabilization and Therapeutic De-escalation in Septic Shock
Phase N/A · 2 location(s) · University Hospital, Brest · NCT06572995
Fluid Challenge and Plasma Volume, During Surgery
Phase 4 · 1 location(s) · Joachim Zdolsek · NCT05726136
Liquid-biopsy Informed Platform Trial to Evaluate CDK4/6-inhibitor Resistant ER+/HER2- Metastatic Breast Cancer
Phase 2 · 10 location(s) · Canadian Cancer Trials Group · NCT05601440
Optimization of Fluid Balance Guided by Bioelectrical Impedance Analysis in Patients Undergoing Continuous Renal Replace
NA · 1 location(s) · Centre Hospitalier Universitaire, Amiens · NCT06799910
Predicting BReast cAncer Response to neoadjuVant Therapy by ctDNA Assessment
Phase N/A · 3 location(s) · Gene Solutions · NCT06087120
Look up another condition
Patient organization or foundation? You can brand this page for your community — your logo, your resources, same honest registry data, kept current daily. Ask about branding →

This page is independently generated by Eichor from the public ClinicalTrials.gov record and re-synced daily. It is not the sponsor's official website unless claimed. Nothing here is medical advice; eligibility is always determined by the study team — talk to your own doctor first.